Spectrum Pharmaceuticals
 |
|
| Public | |
| Traded as |
NASDAQ: SPPI S&P 600 Component |
| Industry | Pharmaceuticals |
| Headquarters | Henderson, Nevada |
|
Key people
|
R. Shrotriya, Chief Executive Officer |
| Website | www.spectrumpharm.com |
Spectrum Pharmaceuticals is an American biopharmaceutical company. The company is located in Irvine, California.
Spectrum develops and markets drugs for treatments in oncology.
A number of drugs are currently investigated in clinical trials.
Spectrum terminated the development of Ozarelix, a luteinizing hormone releasing hormone antagonist for the treatment of benign prostatic hypertrophy in 2010. Other previous drug candidates included ortataxel for the treatment of taxane-refractory tumors, and satraplatin for non-small cell lung cancer.
...
Wikipedia